SCHEMBL13459840

SCHEMBL13459840

O=C(Nc1ccc(-c2cccc3cnccc23)cc1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 4/20 0.53
▸ MAPK14 Q16539 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ TP53 P04637 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ THRB P10828 1/20 0.52
▸ CSF1R P07333 3/20 0.52
▸ RAF1 P04049 1/20 0.51
▸ FLT3 P36888 2/20 0.50
▸ KDR P35968 1/20 0.50
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ PIK3CA P42336 1/20 0.47
▸ TRPV1 Q8NER1 1/20 0.47
▸ AURKA O14965 1/20 0.47
▸ RPS6KB1 P23443 1/20 0.47
▸ AURKB Q96GD4 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ ABL1 P00519 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13459602 0.90 NTRK1 (0.52) BRAFCSF1RRAF1FLT3KDR
SCHEMBL13459839 0.84 RAF1 (0.52) BRAFMAPK14SMN1; SMN2TP53MAPT
SCHEMBL13459944 0.80 CSF1R (0.55) CSF1RFLT3KDRTRPV1AURKB
SCHEMBL13459943 0.74 TEK (0.54) BRAFMAPK14SMN1; SMN2CSF1RRAF1
SCHEMBL13459819 0.73 CSF1R (0.50) BRAFCSF1RRAF1KDRTRPV1
SCHEMBL2342089 0.73 MAPK14 (0.59) BRAFMAPK14MAPTRAF1
SCHEMBL4622855 0.72 ROCK1 (0.69) SMN1; SMN2TP53MAPTMEN1KMT2A
SCHEMBL6848240 0.72 TP53 (0.57) BRAFSMN1; SMN2TP53MAPTTHRB
SCHEMBL22772383 0.72 CSF1R (0.63) BRAFSMN1; SMN2TP53MAPTTHRB
SCHEMBL4248596 0.72 SMN1; SMN2 (0.71) BRAFSMN1; SMN2TP53MAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010032986-A2 NOVEL 5-(4-AMINOPHENYL)-ISOQUINOLINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PRODUCTION METHOD FOR SAME, AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PROPHYLAXIS AND TREATMENT OF MEDICAL CONDITION INDUCED BY RAF KINASE HYPERACTIVITY 주식회사 이큐스팜 (KR) 2010-03-25 — — WO disclosed
Send feedback